EMS 16.7% 2.1¢ eastern metals limited

clyde r u still with us??, page-41

  1. 3,958 Posts.
    lightbulb Created with Sketch. 492
    Jinla where are you getting your facts from?

    The announcement last week stated the next trial will cost under $1.5m, and the company has those funds currently in the bank along with the imminent sale of the surgical business.

    I cannot see the point of completing 2 more trials after the IIa results announced last week. It would be an uneccesary expense and delay the time to market. Give the management team a little more credit than that IMO
 
watchlist Created with Sketch. Add EMS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.